Nature Medicine, Published online: 01 May 2025; doi:10.1038/s41591-025-03684-w
A combination of seroprevalence analyses and modeling indicates that the availability of an infection-blocking CHIKV vaccine would have prevented 88% of cases during an outbreak.
